Sirukumab tolerated in DMARD-refractory patients with RA
Healio.com,
Sirukumab doses of 50 mg every 4 weeks, as well as 100 mg every 2 weeks, were generally tolerated, with measurable efficacy…
Sirukumab tolerated in DMARD-refractory patients with RA
Bioportfolio,
06:30 EDT 26 Mar 2018 | Healio Sirukumab doses of 50 mg every 4 weeks, as well as 100 mg every 2 weeks, were generally tolerated…
Efficacy of sirukumab demonstrated in Japanese RA patients
medwireNews,
medwireNews: Sirukumab monotherapy is well tolerated and has measurable efficacy in Japanese patients with rheumatoid arthritis …